Clinical Trial Update: Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) Infection [EARLY_Phase 1]

View source ↗

Summary

Early-phase PET imaging trial assessing neuroinflammation in patients with neurological symptoms after SARS-CoV-2 infection; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: SARS CoV-2 Post-Acute Sequelae | EARLY_Phase 1 | Status: RECRUITING